Pathogenesis and management of paroxysmal nocturnal haemoglobinuria

Blood Reviews

Volumn 12, Issue 1, 1998, Pages 1-11

  Packman, C H ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Carolina Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; DANAZOL; ERYTHROPOIETIN; FLUOXYMESTERONE; FOLIC ACID; GLUCOCORTICOID; GLYCOSYLPHOSPHATIDYLINOSITOL; IRON; MEMBRANE PROTEIN; STREPTOKINASE; THYMOCYTE ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

BONE MARROW TRANSPLANTATION; COMPLEMENT ACTIVATION; CYTOLYSIS; ERYTHROCYTE TRANSFUSION; FOLIC ACID DEFICIENCY; GENE MUTATION; HEMATOPOIETIC STEM CELL; HEMOLYTIC ANEMIA; HUMAN; IRON DEFICIENCY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 0031946108     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90025-X     Document Type: Article

References (74)

1. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell 1997; 88: 1-4.
2. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. New Engl J Med 1995; 333: 1253-1258.
3. Ware RE, Hall SE, Rosse WF. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. New Engl J Med 1991; 325: 991-996.
4. Rosse WF. Paroxysmal nocturnal hemoglobinuria - present status and future prospects. West J Med 1980; 132: 219-228.
5. Rosse WF. Evolution of clinical understanding: paroxysmal nocturnal hemoglobinuria as a paradigm. Am J Hematol 1993; 42: 122-126.
6. Ham TH. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. A study of the mechanism of hemolysis in relation to acid-base equilibrium. New Engl J Med 1937; 217: 915-917.
7. Ham TH, Dingle JH. Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of hemolytic mechanism with special reference to serum complement. J Clin Invest 1939; 18: 657-672.
8. Rosse WF, Dacie JV. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 1966; 45: 736-748.
9. Hartmann RC, Jenkins DE Jr, Arnold AB. Diagnostic specificity of sucrose hemolysis test for paroxysmal nocturnal hemoglobinuria. Blood 1970; 35: 462-475.
10. Rosse WF, Logue GL, Adams J, Crookston JH. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest 1974; 53: 31-43.
11. Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP. Complement lysis of human erythrocytes. Differing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. J Clin Invest 1979; 64: 428-433.
12. Rouault TA, Rosse WF, Bell S et al. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells. Blood 1978; 51: 325-330.
13. Holguin MH, Parker CJ. Membrane inhibitor of reactive lysis. Curr Top Micro Immunol 1992; 178: 61-85.
14. Hu VW, Nicholson-Weller A. Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization. Proc Natl Acad Sci USA 1985; 82: 5520-5524.
15. Stern M, Rosse WF. Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria bone marrow cells. Blood 1979; 53: 928-934.
16. Aster RH, Enright SE. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for detection of platelet antibodies. J Clin Invest 1969; 48: 1199-1210.
17. Dessypris EN, Clark DA, McKee LC Jr, Krantz SB. Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria. New Engl J Med 1983; 309: 690-693.
18. Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970; 36: 145-152.
19. Auditore JV, Hartmann RC, Flexner JM, Balchum OJ. The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria. Arch Pathol 1960; 69: 534-543.
20. Low MG, Finean JB. Release of alkaline phosphatase from membranes by a phosphatidylinositol-specific phospholipase C. Biochem J 1977; 167: 281-284.
21. Ferguson MAH, Low MG, Cross GAM. Glycosyl-sn-1,2-dimyristylphosphatidylinositol is covalently linked to Trypanosoma brucei variant surface glycoprotein. J Biol Chem 1985; 260: 14547-14555.
22. Davitz MA, Low MG, Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol specific phospholipase C (PIPLC). J Exp Med 1986; 163: 1150-1161.
23. Kinoshita T, Inoue N, Takada J. Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. Ann Rev Med 1996; 47: 1-10.
24. Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 1983; 80: 5066-5070.
25. Medof ME, Kinoshita T, Silber R, Nussenzweig V. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 1985; 82: 2980-2984.
26. Hänsch GM, Hammer CH, Vangun P, Shin ML. Homologous species restriction in lysis of erythrocytes by terminal complement proteins. Proc Natl Acad Sci USA 1981; 78: 5118-5121.
27. Rosenfeld SI, Packman CH, Jenkins DE, Countryman JK, Leddy JP. Complement lysis of human erythrocytes III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells. J Immunol 1980; 125: 2063-2068.
28. Zalman LS, Wood LM, Müller-Eberhard HJ. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci USA 1986; 83: 6975-6979.
29. Schönermark S, Rauterberg EW, Shin ML, Loke S, Roelcke D, Hänsch GM. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol 1986; 136: 1772-1776.
30. Zalman LS. Homologous restriction factor. Curr Top Micro Immunol 1992; 178: 87-99.
31. Hänsch GM, Schönermark S, Roelcke D. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis of C5b-9. J Clin Invest 1987; 80: 7-12.
32. Shishishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal hemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol 1993; 85: 378-386.
33. Yamashina M, Ueda E, Kinoshita T et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. New Engl J Med 1990; 323: 1184-1189.
34. Telen MJ, Green AM. The INAB phenotype: characterization of the membrane protein and complement regulatory defect. Blood 1989; 74: 437-441.
35. Holguin MH, Wilcox LA, Bernshaw NJ, Rosse WF, Parker CJ. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1990; 84: 2133-2137.
36. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993; 82: 1192-1196.
37. Ploug M, Plesner T, Ronne E et al. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood 1992; 79: 1447-1455.
38. Young NS. The problem of clonality in aplastic anemia: Dr. Dameskek's riddle, restated. Blood 1992; 79: 1385-1392.
39. Maciejewski JP, Sloand EM, Sato T, Anderson S, Young NS. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood 1997; 89: 1173-1181.
40. Kawagoe K, Kitamura D, Okabe M et al. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 3600-3606.
41. Cross GAM. Cellular and genetic aspects of antigenic variation in trypanosomes. Annu Rev Immunol 1990; 8: 83-110.
42. Luzzatto L, Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol 1996; 3: 101-110.
43. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 3277-3286.
44. Miyata T, Takada J, Iida J et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993; 259: 1318-1320.
45. Kinoshita T, Inoue N, Takeda J. Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria. Adv Immunol 1995; 60: 57-103.
46. Endo M, Ware RE, Vreeke TM et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 2546-2557.
47. Issaragrishil S, Piankijagum A, Tang-naitrisorana Y. Corticosteroid therapy in paroxysmal nocturnal hemoglobinuria. Am J Hematol 1987; 25: 77-83.
48. Rosse WF. Treatment of paroxysmal nocturnal hemoglobinuria. Blood 1982; 60: 20-23.
49. Rosse WF. Paroxysmal nocturnal hemoglobinuria. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds). Hematology (2nd edn). Edinburgh: Churchill Livingstone, 1995
50. Brecher ME, Taswell HF. Paroxysmal nocturnal hemoglobinuria and transfusion of washed red cells. Transfusion 1989; 29: 681-685.
51. Rosse WF. Transfusion in paroxysmal nocturnal hemoglobinuria. To wash or not to wash? Transfusion 1989; 29: 663-664.
52. Bourantas K. High-dose recombinant human erythropoietin and low-dose corticosteroids for treatment of anemia in paroxysmal nocturnal hemoglobinuria. Acta Hematol 1994; 91: 62-65.
53. Balleari E, Gatti AM, Mareni C. Massa G, Marmont AM, Ghio R. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria. Haematologica 1996; 81: 143-147.
54. Rosse WF, Gutterman LA. The effect of iron therapy in paroxysmal nocturnal hemoglobinuria. Blood 1970; 36: 559-565.
55. Hartmann RC, Jenkins DE Jr, McKee LC, Heyssel RM. Paroxysmal nocturnal hemoglobinuria: clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine 1966; 45: 331-363.
56. Yoshimura Y, Nakayama A, Hama H et al. Treatment of paroxysmal nocturnal hemoglobinuria with danazol. Jap J Clin Hematol 1990; 31: 1489-1492.
57. Murakawa M, Shibuya T, Harada M et al. Danazol treatment for paroxysmal nocturnal hemoglobinuria. Jap J Med 1990; 29: 417-422.
58. Sanchez-Valle E, Morales-Polanco MR, Gomez-Morales E, Gutierrez-Alamillo LI, Gutierrez-Espindola G, Pizzuto-Chavez J. Treatment of paroxysmal nocturnal hemoglobinuria with antilymphocyte globulin. Rev de Investigacio Clinica 1993; 45: 457-461.
59. Paquette RL, Yoshimura R, Veiseh C, Kunkel L, Gajewski J, Rosen PJ. Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol 1997; 96: 92-97.
60. Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol 1995; 23: 81-87.
61. van Kamp H, van Imhoff GW, de Wolf JT, Smit JW, Halie MR, Vellenga E. The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1995; 89: 79-82.
62. Antin JH, Ginsburg D, Smith RE, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 1985; 66: 1247-1250.
63. Kawahara K, Witherspoon RP, Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 1992; 39: 283-288.
64. Endo M, Beatty PG, Vreeke TM, Wittwer CT, Singh SP, Parker CJ. Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria. In vivo evidence that the mutant stem cells have a survival advantage. Blood 1996; 88: 742-750.
65. Kolb HJ, Holler E, Bender-Götze Ch et al. Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria. Bone Marrow Transplant 1989; 4: 29-34.
66. Prince GM, Nguyen M, Lazarus HM, Brodsky RA, Terstappen LW, Medof ME. Peripheral blood harvest of unaffected CD34 + CD38-hematopoietic precursors in paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 3381-3386.
67. Mathieu D, Rahmouni A, Villeneuve P, Anglade MC, Rochant H, Vasile N. Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria. Blood 1995; 85: 3283-3288.
68. Sholar PW, Bell WR. Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Int Med 1985; 103: 539-541.
69. McMullin MF, Hillmen P, Jackson J, Ganly P, Luzzano L. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med 1984; 235: 85-89.
70. Osjogicjo T, Fukatsu H, Itoh S, Shimamoto K, Sakuma S. Budd-Chiari syndrome with long segmental inferior vena cava obstruction: treatment with thrombolysis, angioplasty, and intravascular stents. J Vasc Interv Radiol 1992; 3: 421-425.
71. Kwan T, Hansard P. Recombinant tissue-plasminogen activator for acute Budd-Chiari syndrome secondary to paroxysmal nocturnal hemoglobinuria. NY State J Med 1992; 92: 109-110.
72. Greene MF, Frigoletto FD Jr, Claster S, Rosenthal D. Pregnancy and paroxysmal nocturnal hemoglobinuria: report of a case and review of the literature. Obstet Gynecol 1983; 38: 591-596.
73. Solal-Céligny P, Tertian G, Fernandez H et al. Pregnancy and paroxysmal nocturnal hemoglobinuria. Arch Intern Med 1988; 148: 593-595.
74. Hurd WW, Miodovnik M, Stys SJ. Pregnancy associated with paroxysmal nocturnal hemoglobinuria. Obstet Gynecol 1982; 60: 742-746.